MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CLNN — Clene Inc. Common Stock
NasdaqClene Inc. Common Stock
$4.08
+0.06(+1.49%)
- O
- 4.08
- H
- 4.17
- L
- 3.97
- V
- 57.45K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About CLNN
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateDec 31, 2020
Employees79
Stock ExchangeNasdaq
Ticker SymbolCLNN
Websitehttps://www.clene.com
Key Financial Statistics
| Market Cap | $61.12M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $3.25 - $13.50 |
| 52-Week Avg Volume | 217.2K |
| VWAP | $4.03 |
| Transactions | 934 |
| Total Recorded Bars | 1,999 days |